Anzeige
Mehr »
Login
Montag, 17.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neue Kursrakete – Deutsche Aktie im Höhenflug
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404JF | ISIN: US8964385046 | Ticker-Symbol: TRB
Lang & Schwarz
17.06.24
13:06 Uhr
1,530 Euro
-1,530
-100,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRINITY BIOTECH PLC ADR Chart 1 Jahr
5-Tage-Chart
TRINITY BIOTECH PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
1,5001,56013:07
0,0000,00023.05.

Aktuelle News zur TRINITY BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.06.Trinity Biotech plc: Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association8
03.06.Trinity Biotech plc: Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology177DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...
► Artikel lesen
28.05.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer2
24.05.Earnings call: Trinity Biotech eyes growth with HIV test and CGM tech4
23.05.Trinity Biotech GAAP EPADS of -$0.37, revenue of $14.7M3
23.05.Trinity Biotech plc: Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance93-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million by Q2 2025- -Strong sequential 39% Q/Q growth...
► Artikel lesen
21.05.Trinity Biotech plc to Announce Q1 2024 Financial Results5
16.05.Trinity Biotech Announces Strategic Collaboration With Medical AI Co. PulseAI2
16.05.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer3
16.05.Trinity Biotech plc: Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI1
13.05.Trinity Biotech plc: Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales4
08.05.Trinity Biotech plc: Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development2
01.05.Trinity Biotech files to sell 2.80M ADS for holders5
30.04.TRINITY BIOTECH PLC - 20-F, Annual and transition report of foreign private issuers2
30.04.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer4
08.04.Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript8
05.04.TRINITY BIOTECH PLC - 6-K, Report of foreign issuer1
04.04.Trinity Biotech reports Q4 results4
04.04.Trinity Biotech plc: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates1.348DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including...
► Artikel lesen
28.03.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results3
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1